Learning Objectives:
1. Outline MRI modalities used in clinical care and research for ataxias
2. Describe the potential uses of imaging biomarkers/surrogate markers in ataxia trials
3. Summarize the steps needed to validate imaging outcomes for clinical research and therapeutic trials
Session date:
04/12/2024 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Dr. Guilin Oz